3rd-4th February, 2022

4th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference

San Diego, USA

The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.

However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress. Learn about microbial innovation and applying the new microbiome findings along with the regulatory pathways for better therapeutic development. Also, witness discussions on Microbiome vs probiotics and the link between them.

Connect with biotech, pharma, academicians and investors at 4th Annual Next Gen Microbiome and Probiotics Conference on 3-4 February 2022 in San Diego, USA, discussing the most ingenious research and technological advances. Key sessions on Applying new microbiome findings, regulatory updates, brandng and marketing of probiotics along with discussion on effective translation from R& D to commercialization.

WHAT TO EXPECT
Key Highlights
  • Microbial Innovations- Applying new microbiome findings
  • Regulatory updates
  • Microbiome as a science and its clinical applications- skin, gut & women’s health
  • Pediatrics and infant health
  • Analyzing the concept of Probiotics
  • Strain Identification
  • R & D to commercialization- effectively translating research into commercialization
  • Right branding and marketing of probiotics products
  • The Future of Probiotics in the Consumer Marketplace
Who Should Attend?

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals from pharmaceuticals, nutraceuticals and therapeutics-based organizations from the departments of:

  • Microbiome discovery
  • Department of Biochemistry and Immunology
  • Microbiome science
  • Microbiology
  • Biological Science
  • Gut Biology
  • Human microbiome
CONFERENCE AGENDA
EFFECTIVELY TRANSLATING MICROBIOME RESEARCH INTO PRODUCTS
THE FUTURE OF PROBIOTICS IN THE CONSUMER MARKETPLACE
CONFERENCE SPEAKERS
Advisors
 Julius Goepp

Julius Goepp

Founder, CEO
Scaled Microbiomics

Julius Goepp

Founder, CEO
Scaled Microbiomics
 Emily Stein

Emily Stein

CEO
Primal Health Inc.

Emily Stein

CEO
Primal Health Inc.
Yug Varma

Yug Varma

CEO
Phi Therapeutics

Yug Varma

CEO
Phi Therapeutics
 Nicole M. Scott

Nicole M. Scott

CEO and Founder
Cybele Microbiome

Nicole M. Scott

CEO and Founder
Cybele Microbiome
Speakers
 Julius Goepp

Julius Goepp

Founder, CEO
Scaled Microbiomics

Julius Goepp

Founder, CEO
Scaled Microbiomics
 Emily Stein

Emily Stein

CEO
Primal Health Inc.

Emily Stein

CEO
Primal Health Inc.
Yug Varma

Yug Varma

CEO
Phi Therapeutics

Yug Varma

CEO
Phi Therapeutics
 Nicole M. Scott

Nicole M. Scott

CEO and Founder
Cybele Microbiome

Nicole M. Scott

CEO and Founder
Cybele Microbiome
 Julie Schwedock

Julie Schwedock

Associate Director, Microbial Development Team
Takeda Pharmaceuticals

Julie Schwedock

Associate Director, Microbial Development Team
Takeda Pharmaceuticals
Ross Youngs

Ross Youngs

CEO & Founder
Biosortia Pharmaceuticals

Ross Youngs

CEO & Founder
Biosortia Pharmaceuticals
Denise Kelly

Denise Kelly

Investment Advisor
Seventure

Denise Kelly

Investment Advisor
Seventure
Maya Ivanjesku

Maya Ivanjesku

Chief Scientific Officer
Dakota Biotech

Maya Ivanjesku

Chief Scientific Officer
Dakota Biotech
SPONSORS
Gold
example-image

Eremid Research Services

Exhibition Partner
example-image

Microbiology International

LOCATION
San Diego, USA
About the Hotel

PAST EVENT GALLERY